Astellas names new head of global development
This article was originally published in Scrip
Executive Summary
Astellas Pharma has named Eric Terhaerdt senior vice-president of global development operations. Mr Terhaerdt will be located at Astellas' headquarters for the Americas in Northbrook, Illinois, and will report to Dr Bernie Zeiher, executive vice-president of global development. In this role he will be responsible for establishing the global direction of the drug development operations of Astellas in the Netherlands and the US, and will work closely with Japanese development operations to ensure global operational effectiveness and efficiency. Prior to joining Astellas, Mr Terhaerdt spent more than 20 years with AstraZeneca, serving in a variety of global leadership roles with increasing responsibility, in the areas of clinical research, clinical development, clinical quality, strategy and performance and scientific and technical evaluations.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.